Ophthalmology
The AJMC® Ophthalmology compendium is a comprehensive resource for clinical news and expert insights for treatment of disorders of the eye.
Latest News
FDA Delivers CRL for Longer Dosage Intervals in Aflibercept for DME, Wet AMD
Reproxalap Receives Complete Response Letter From FDA for Use in Dry Eye Disease
Prevalence, Severity of Astigmatism Increased in Children After Pandemic
Retraction: Water-Free Topical Cyclosporine Improved Dryness Score in Dry Eye
Doctors Can Work With Patients to Be More Proactive in Glaucoma Care: Christine Funke, MD
Evolving Treatment Landscape in nAMD, DME Reduces Patient Burden, Improves Outcomes: Casey Koch, PharmD
Treating Glaucoma Has Evolved in Patients, Physicians Alike: Christine Funke, MD
Cyclosporine Ophthalmic Solution Safe, Accessible in Uncontrollable Dry Eye
Cyclosporine Ophthalmic Solution 0.09% Effective, Safe in Treating Dry Eye
Symptoms of AMD Not Always Obvious to Patients
Future Treatments for AMD Could Mitigate Burden on Patients
Knowing Risk Factors for AMD Can Lead to Best Prognosis
Distortion, Central Blurriness Among Major Symptoms of AMD
Consistent Screening Important for Addressing Glaucoma
Application of Recent Data in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Managed Care Insights and Strategies
Leveraging Novel Therapies to Transform Demodex Blepharitis Care
Patient-Centered Treatment Plans for Management of Neovascular (Wet) AMD and Diabetic Macular Edema: Insights on Recent Efficacy, Safety, and Real-World Data to Improve Adherence and Outcomes
Leveraging Novel Therapies to Transform Demodex Blepharitis Care (6/11)
Integrating Multi-Cancer Early Detection Tests Into Clinical Practice: The Health Economics Perspective for Managed Care Professionals
The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes
More News
Dry Eye Symptom Frequency, Severity Reduced When Using Perfluorohexyloctane
